Form D · Biotechnology

Koios Medical, Inc.

New York, NY · CIK 0001764417

Offering snapshot reported Dec 23, 2025 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 23, 2025InitialYet to sellNo comparison0SEC filing
Jun 24, 2024Amendment$170,000-$129,830,000vs May 28, 20244SEC filing
May 28, 2024Initial$130,000,000No comparison4SEC filing
Feb 17, 2023Initial$7,999,996No comparison1SEC filing
Aug 8, 2022Initial$2,598,156No comparison25SEC filing
Feb 3, 2021Initial$280,000No comparison7SEC filing
Jan 11, 2019Initial$5,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-567947

Source: Form D, filed Dec 23, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Graham Anderson Executive, Promoter
Mark Glasgold Director
Christine Li Director
Robert Chad Mcclennan Executive, Promoter
Robert Chad Mc Clennan Executive, Promoter
Gregory Moran Director
William E. Peterson Director
Christine Li Shuling Executive, Promoter
John Walker Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
242 W. 38 Th Street 14 Th Floor
New York, NY, 10018